EyeBio
is an England-based ophthalmology biotech company that researches and develops novel therapies for the treatment of eye diseases... Read moreEyeBio
is an England-based ophthalmology biotech company that researches and develops novel therapies for the treatment of eye diseases... Read more
News
Sep 05, 2024
Yahoo
EyeBio: MSD and EyeBio launch trial of Restoret for diabetic macular oedema
Jul 12, 2024
Pharamceutical Technology
EyeBio: MSD closes $1.3bn EyeBio acquisition, plans pivotal trial for lead asset
Jun 28, 2024
Cision
Press Release: EyeBio : BioStock: Annexin comments on acquisition and focus on ANXV in ophthalmology
May 30, 2024
Global Legal Chronicle
EyeBio: Merck KGaA, Darmstadt, Germany's $600 Million Acquisition of Mirus Bio
May 30, 2024
European Biotechnology
EyeBio: MSD grabs Eyebiotech Ltd for US$1.3bn upfront
May 30, 2024
The Financial Times
EyeBio: Merck signs $3bn deal for Kate Bingham-backed eye disease biotech
May 29, 2024
MedCity News
EyeBio: Merck Sees Pipeline Diversification Opportunity in $1.3B EyeBio Acquisition
May 29, 2024
PE Hub Europe
EyeBio: Jeito Capital to sell EyeBiotech to Merck & Co for $3bn
May 29, 2024
MarketWatch
EyeBio: Merck could pay up to $3 billion to boost its retinal disease candidate pipeline
May 29, 2024
Benzinga
EyeBio: Merck Reportedly Nearing $1.3B Acquisition Of EyeBio To Expand Eye-Care Market Presence
EyeBio Competitors
1
2
3
4
5
6